Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

被引:179
|
作者
Zhong, JiuChang
Guo, Danny
Chen, Christopher B.
Wang, Wang [5 ]
Schuster, Manfred [2 ]
Loibner, Hans [2 ]
Penninger, Josef M. [3 ]
Scholey, James W. [4 ]
Kassiri, Zamaneh [5 ]
Oudit, Gavin Y. [1 ,5 ]
机构
[1] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada
[2] Apeiron Biol, Vienna, Austria
[3] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria
[4] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada
[5] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada
基金
中国国家自然科学基金;
关键词
angiotensin I; hypertension I; renal fibrosis; signal transduction; CHRONIC KIDNEY-DISEASE; PROXIMAL TUBULAR CELLS; INDUCED HYPERTENSION; PATHOLOGICAL HYPERTROPHY; ACE2; INJURY; EXPRESSION; MICE; DYSFUNCTION; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.110.164244
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase capable of metabolizing angiotensin (Ang) II into Ang 1 to 7. We hypothesized that ACE2 is a negative regulator of Ang II signaling and its adverse effects on the kidneys. Ang II infusion (1.5 mg/kg(-1)/d(-1)) for 4 days resulted in higher renal Ang II levels and increased nicotinamide adenine dinucleotide phosphate oxidase activity in ACE2 knockout (Ace2(-/y)) mice compared to wild-type mice. Expression of proinflammatory cytokines, interleukin-1 beta and chemokine (C-C motif) ligand 5, were increased in association with greater activation of extracellular-regulated kinase 1/2 and increase of protein kinase C-alpha levels. These changes were associated with increased expression of fibrosis-associated genes (alpha-smooth muscle actin, transforming growth factor-beta, procollagen type I alpha 1) and increased protein levels of collagen I with histological evidence of increased tubulointerstitial fibrosis. Ang II-infused wild-type mice were then treated with recombinant human ACE2 (2 mg/kg(-1)/d(-1), intraperitoneal). Daily treatment with recombinant human ACE2 reduced Ang II-induced pressor response and normalized renal Ang II levels and oxidative stress. These changes were associated with a suppression of Ang II-mediated activation of extracellular-regulated kinase 1/2 and protein kinase C pathway and Ang II-mediated renal fibrosis and T-lymphocyte-mediated inflammation. We conclude that loss of ACE2 enhances renal Ang II levels and Ang II-induced renal oxidative stress, resulting in greater renal injury, whereas recombinant human ACE2 prevents Ang II-induced hypertension, renal oxidative stress, and tubulointerstitial fibrosis. ACE2 is an important negative regulator of Ang II-induced renal disease and enhancing ACE2 action may have therapeutic potential for patients with kidney disease. (Hypertension. 2011;57:314-322.). Online Data Supplement
引用
收藏
页码:314 / U338
页数:18
相关论文
共 50 条
  • [21] Modulation of cutaneous inflammation by angiotensin-converting enzyme
    Scholzen, TE
    Ständer, S
    Riemann, H
    Brzoska, T
    Luger, TA
    JOURNAL OF IMMUNOLOGY, 2003, 170 (07): : 3866 - 3873
  • [22] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
    Kyrmizakis, DE
    Papadakis, CE
    Liolios, AD
    Karatzanis, AD
    Malandrakis, S
    Skoulakis, CE
    Bizakis, JG
    Velegrakis, GA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (12) : 1416 - 1419
  • [23] PREVENTION OF PATHOLOGICAL HYPERTROPHY, MYOCARDIAL FIBROSIS AND CARDIAC DYSFUNCTION BY ANGIOTENSIN-CONVERTING ENZYME 2
    Zhong, J.
    Basu, R.
    Guo, D.
    Chow, F. L.
    Bryns, S.
    Shuster, M.
    Loibner, H.
    Wang, X.
    Penninger, J. M.
    Kassiri, Z.
    Oudit, G. Y.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 72D - 72D
  • [24] Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2
    Masson, Rachel
    Nicklin, Stuart A.
    Craig, Margaret Anne
    McBride, Martin
    Gilday, Kirsten
    Gregorevic, Paul
    Allen, James M.
    Chamberlain, Jeffrey S.
    Smith, Godfrey
    Graham, Delyth
    Dominiczak, Anna F.
    Napoli, Claudio
    Baker, Andrew H.
    HYPERTENSION, 2009, 53 (04) : 694 - U207
  • [25] EXPRESSION OF ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN-CONVERTING ENZYME 2 IN PATIENTS WITH CHRONIC HEART FAILURE
    Wang, Jiang
    Li, Nan
    Li, Ai-Min
    Song, Rong
    Gao, Feng
    Geng, Zhao-Hua
    HEART, 2011, 97
  • [26] EXPRESSION OF ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN-CONVERTING ENZYME 2 IN PATIENTS WITH CHRONIC HEART FAILURE
    Wang, Jiang
    Li, Nan
    Li, Ai-min
    Song, Rong
    Gao, Feng
    Geng, Zhao-Hua
    HEART, 2011, 97 : A52 - A52
  • [27] Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
    Liu, Shuyu
    Liu, Junjun
    Miura, Yukie
    Tanabe, Chiaki
    Maeda, Tomoji
    Terayama, Yasuo
    Turner, Anthony J.
    Zou, Kun
    Komano, Hiroto
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) : 1178 - 1186
  • [28] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers - Reply
    Healey, JS
    Morillo, CA
    Connolly, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 890 - 891
  • [29] Novel roles of the renal angiotensin-converting enzyme
    Giani, Jorge F.
    Veiras, Luciana C.
    Shen, Justin Z. Y.
    Bernstein, Ellen A.
    Cao, DuoYao
    Okwan-Duodu, Derick
    Khan, Zakir
    Gonzalez-Villalobos, Romer A.
    Bernstein, Kenneth E.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 529
  • [30] Expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in patients with chronic heart failure
    Wang, Jiang
    Li, Nan
    Li, Ai-min
    Song, Rong
    Gao, Feng
    Geng, Zhao-Hua
    Zhu, Shan-Jun
    CARDIOLOGY, 2011, 120 : 27 - 27